Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo

Robert J. Turesky; Paul Vouros

doi:10.1016/j.jchromb.2003.10.053

Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo

Robert J. Turesky, Paul Vouros

Medicinal Chemistry

Research output: Contribution to journal › Review article › peer-review

96 Scopus citations

Abstract

The detection and quantification of heterocyclic aromatic amine (HAA)-DNA adducts, critical biomarkers in interspecies extrapolation of toxicity data for human risk assessment, remains a challenging analytical problem. The two main analytical methods currently in use to screen for HAA-DNA adducts are the ³²P-postlabeling assay and mass spectrometry, using either accelerated mass spectrometry (AMS) or liquid chromatography and electrospray ionization mass spectrometry (LC-ESI-MS). In this review, the principal methods to synthesize and characterize DNA adducts, and the methods applied to measure HAA-DNA adduct in vitro and vivo are discussed.

Original language	English (US)
Pages (from-to)	155-166
Number of pages	12
Journal	Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume	802
Issue number	1
DOIs	https://doi.org/10.1016/j.jchromb.2003.10.053
State	Published - Mar 25 2004

Bibliographical note

Funding Information:
This work was supported in part by a grant (PV) from the National Cancer Institute (1R01CA69390).

Keywords

DNA
Heterocyclic aromatic amine-DNA adducts
Reviews

Access

10.1016/j.jchromb.2003.10.053

OpenUrl availability

Full text

Cite this

@article{a46d0f7d1fdb4c6090c64ce7745bf72f,

title = "Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo",

abstract = "The detection and quantification of heterocyclic aromatic amine (HAA)-DNA adducts, critical biomarkers in interspecies extrapolation of toxicity data for human risk assessment, remains a challenging analytical problem. The two main analytical methods currently in use to screen for HAA-DNA adducts are the 32P-postlabeling assay and mass spectrometry, using either accelerated mass spectrometry (AMS) or liquid chromatography and electrospray ionization mass spectrometry (LC-ESI-MS). In this review, the principal methods to synthesize and characterize DNA adducts, and the methods applied to measure HAA-DNA adduct in vitro and vivo are discussed.",

keywords = "DNA, Heterocyclic aromatic amine-DNA adducts, Reviews",

author = "Turesky, {Robert J.} and Paul Vouros",

note = "Funding Information: This work was supported in part by a grant (PV) from the National Cancer Institute (1R01CA69390). ",

year = "2004",

month = mar,

day = "25",

doi = "10.1016/j.jchromb.2003.10.053",

language = "English (US)",

volume = "802",

pages = "155--166",

journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",

issn = "1570-0232",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo

AU - Turesky, Robert J.

AU - Vouros, Paul

N1 - Funding Information: This work was supported in part by a grant (PV) from the National Cancer Institute (1R01CA69390).

PY - 2004/3/25

Y1 - 2004/3/25

N2 - The detection and quantification of heterocyclic aromatic amine (HAA)-DNA adducts, critical biomarkers in interspecies extrapolation of toxicity data for human risk assessment, remains a challenging analytical problem. The two main analytical methods currently in use to screen for HAA-DNA adducts are the 32P-postlabeling assay and mass spectrometry, using either accelerated mass spectrometry (AMS) or liquid chromatography and electrospray ionization mass spectrometry (LC-ESI-MS). In this review, the principal methods to synthesize and characterize DNA adducts, and the methods applied to measure HAA-DNA adduct in vitro and vivo are discussed.

AB - The detection and quantification of heterocyclic aromatic amine (HAA)-DNA adducts, critical biomarkers in interspecies extrapolation of toxicity data for human risk assessment, remains a challenging analytical problem. The two main analytical methods currently in use to screen for HAA-DNA adducts are the 32P-postlabeling assay and mass spectrometry, using either accelerated mass spectrometry (AMS) or liquid chromatography and electrospray ionization mass spectrometry (LC-ESI-MS). In this review, the principal methods to synthesize and characterize DNA adducts, and the methods applied to measure HAA-DNA adduct in vitro and vivo are discussed.

KW - DNA

KW - Heterocyclic aromatic amine-DNA adducts

KW - Reviews

UR - http://www.scopus.com/inward/record.url?scp=1242328728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242328728&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2003.10.053

DO - 10.1016/j.jchromb.2003.10.053

M3 - Review article

C2 - 15036007

AN - SCOPUS:1242328728

SN - 1570-0232

VL - 802

SP - 155

EP - 166

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

IS - 1

ER -

Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this